Andrea Newkirk

Stock Analyst at Goldman Sachs

(0.36)

# 4,159

Out of 4,944 analysts

3

Total ratings

n/a

Success rate

-9.34%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Andrea Newkirk

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ALKS Alkermes	Initiates: Buy	$43	$28.64	+50.14%	1	Jul 15, 2025
	RVMD Revolution Medicines	Initiates: Buy	$65	$36.09	+80.13%	1	Jul 15, 2025
	ETNB 89bio	Initiates: Neutral	$11	$9.14	+20.35%	1	Mar 14, 2025

Alkermes

Jul 15, 2025

Initiates: Buy

Price Target: $43

Current: $28.64

Upside: +50.14%

Revolution Medicines

Jul 15, 2025

Initiates: Buy

Price Target: $65

Current: $36.09

Upside: +80.13%

89bio

Mar 14, 2025

Initiates: Neutral

Price Target: $11

Current: $9.14

Upside: +20.35%